People with mild Alzheimer's disease who received showed improvement in memory, language abilities, processing speed, and quality of life, AMBAR trial data showed. (Alzheimer's & Dementia)
Fewer people treated with erenumab stopped taking the drug due to adverse events compared with those treated with topiramate (Topamax) in the phase IV HER-MES trial. (Cephalalgia)
Biogen said it is reviewing adverse events possibly linked to its Alzheimer's drug aducanumab (Aduhelm), "including the whose cause of death remains under investigation and who was diagnosed during hospitalization with cerebral edema thought to be ARIA-E." (Endpoints News)
Higher frequency of fish intake was associated with lower burden in older adults, especially among people younger than 75. (Neurology)
The , originally slated to focus on treatment targeting tau among people with dominantly inherited Alzheimer's disease, will include an arm that evaluates two drugs targeting amyloid and tau at the same time. (Washington University School of Medicine)
Distal sensory was linked to increased activity in the anterior insula, which is involved in predicting pain. (Brain Communications)
Amylyx Pharmaceuticals submitted a new drug application to the FDA for (sodium phenylbutyrate and taurursodiol), its investigational ALS treatment.
Sharif Tabebordbar, PhD, sought to cure his father's facioscapulohumeral muscular dystrophy. He may not be able to do that, but his work may help others. (New York Times)
The FDA (Eprontia) for seizures associated with epilepsy and for migraine prevention, Azurity Pharmaceuticals announced.
A reproductive history that signaled more estrogen exposure was linked with in midlife women. (Neurology)